Fresolimumab, CAS [[948564-73-6]]

Produktübersicht

• Artikelname: Fresolimumab, CAS [[948564-73-6]]
• Artikelnummer: MCE-HY-P99020
• Hersteller Artikelnummer: HY-P99020
• Alternativnummer: MCE-HY-P99020-1MG,MCE-HY-P99020-25MG,MCE-HY-P99020-5MG,MCE-HY-P99020-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: GC1008

Produktbeschreibung

Fresolimumab (GC1008) is a human monoclonal antibody against TGF-beta that neutralizes all mammalian active subtypes of TGF-beta. The binding affinity of Fresolimumab to TGF-beta2 is 1.8 nM. Fresolimumab improves Bleomycin (HY-108345)-induced acute lung injury. Fresolimumab radiolabeled with 89Zr can be used for PET analysis of TGF-beta expression, antibody uptake and organ distribution. Fresolimumab can be used in the study of cancer, osteogenesis imperfecta, fibrosis and kidney disease[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: (144.4 kDa)
• Reinheit: 99.51
• CAS Nummer: [948564-73-6]
• Target-Kategorie: TGF-beta/Smad

Anwendungsbeschreibung

• Anwendungsbeschreibung: Inhibitory Antibodies